These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12588218)

  • 21. Novel treatment for cheilitis glandularis.
    Bovenschen HJ
    Acta Derm Venereol; 2009; 89(1):99-100. PubMed ID: 19197557
    [No Abstract]   [Full Text] [Related]  

  • 22. Arterial and venous thrombotic complications with thalidomide in multiple myeloma.
    Alkindi S; Dennison D; Pathare A
    Arch Med Res; 2008 Feb; 39(2):257-8. PubMed ID: 18164975
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of recalcitrant granulomatous rosacea with oral thalidomide and topical pimecrolimus.
    Qian G; Liu T; Zhou C; Zhang Y
    J Dermatol; 2015 May; 42(5):539-40. PubMed ID: 25753523
    [No Abstract]   [Full Text] [Related]  

  • 24. Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.
    Okon L; Rosenbach M; Krathen M; Rose M; Propert K; Okawa J; Werth V
    J Am Acad Dermatol; 2014 Mar; 70(3):583-4. PubMed ID: 24528907
    [No Abstract]   [Full Text] [Related]  

  • 25. Desensitization to thalidomide in a patient with multiple myeloma.
    Nucera E; Schiavino D; Hohaus S; Leone G; Buonomo A; Lombardo C; Patriarca G
    Clin Lymphoma Myeloma; 2008 Jun; 8(3):176-8. PubMed ID: 18650182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prurigo nodularis of Hyde treated with low-dose thalidomide.
    Orlando A; Renna S; Cottone M
    Eur Rev Med Pharmacol Sci; 2009; 13(2):141-5. PubMed ID: 19499850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bradycardia during therapy for multiple myeloma with thalidomide.
    Fahdi IE; Gaddam V; Saucedo JF; Kishan CV; Vyas K; Deneke MG; Razek H; Thorn B; Bissett JK; Anaissie EJ; Barlogie B; Mehta JL
    Am J Cardiol; 2004 Apr; 93(8):1052-5. PubMed ID: 15081457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide and recurrent aphthous stomatitis: a follow-up study.
    Bonnetblanc JM; Royer C; Bedane C
    Dermatology; 1996; 193(4):321-3. PubMed ID: 8993957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Discoid lupus, recurrent aphthosis. New indications for thalidomide?].
    MMW Fortschr Med; 2001 Feb; 143(8):33. PubMed ID: 11265535
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful long-term treatment with cyclosporin A in protein losing gastroenteropathy.
    Sunagawa T; Kinjo F; Gakiya I; Hokama A; Kugai Y; Matayoshi R; Yonamine Y; Tomiyama R; Saito A
    Intern Med; 2004 May; 43(5):397-9. PubMed ID: 15206552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series.
    Noel N; Mahlaoui N; Blanche S; Suarez F; Coignard-Biehler H; Durieu I; Godeberge P; Sokol H; Catherinot E; Poiree S; Chapdelaine H; Dunogue B; Bodemer C; Lecuit M; Fischer A; Lortholary O; Hermine O
    J Allergy Clin Immunol; 2013 Oct; 132(4):997-1000.e1-4. PubMed ID: 23791514
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome.
    Zhang L; Au S; Aronson IK
    Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of cutaneous sarcoidosis with thalidomide.
    Nguyen YT; Dupuy A; Cordoliani F; Vignon-Pennamen MD; Lebbé C; Morel P; Rybojad M
    J Am Acad Dermatol; 2004 Feb; 50(2):235-41. PubMed ID: 14726878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red scalp disease--a rosacea-like dermatosis of the scalp? Successful therapy with oral tetracycline.
    Oberholzer PA; Nobbe S; Kolm I; Kerl K; Kamarachev J; Trüeb RM
    Dermatology; 2009; 219(2):179-81. PubMed ID: 19590169
    [No Abstract]   [Full Text] [Related]  

  • 35. Thalidomide approval brings tight restrictions on access.
    Am J Health Syst Pharm; 1998 Sep; 55(17):1746, 1749. PubMed ID: 9775332
    [No Abstract]   [Full Text] [Related]  

  • 36. Thromboembolism in patients on thalidomide for myeloma.
    Bowcock SJ; Rassam SM; Ward SM; Turner JT; Laffan M
    Hematology; 2002 Feb; 7(1):51-3. PubMed ID: 12171777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.
    Marchetti M; Barosi G; Balestri F; Viarengo G; Gentili S; Barulli S; Demory JL; Ilariucci F; Volpe A; Bordessoule D; Grossi A; Le Bousse-Kerdiles MC; Caenazzo A; Pecci A; Falcone A; Broccia G; Bendotti C; Bauduer F; Buccisano F; Dupriez B
    J Clin Oncol; 2004 Feb; 22(3):424-31. PubMed ID: 14752066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous sarcoidosis successfully treated with low doses of thalidomide.
    Rousseau L; Beylot-Barry M; Doutre MS; Beylot C
    Arch Dermatol; 1998 Aug; 134(8):1045-6. PubMed ID: 9722748
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of cheilitis glandularis superimposed on oral lichen planus: successful palliative treatment with topical tacrolimus and pimecrolimus.
    Erkek E; Sahin S; Kilic R; Erdogan S
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):999-1000. PubMed ID: 17659026
    [No Abstract]   [Full Text] [Related]  

  • 40. Very low doses of thalidomide as single agent in relapsed/refractory multiple myeloma.
    Guglielmelli T; Capella S; Saglio G
    Acta Haematol; 2006; 116(1):70-1. PubMed ID: 16809894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.